Tetsuo Kubota Selected Research

Tetsuo Kubota Research Topics

Disease

8	Seizures (Absence Seizure) 01/2021 - 06/2004
8	Rheumatoid Arthritis 11/2013 - 01/2005
5	Inflammation (Inflammations) 01/2021 - 01/2007
5	Cryopyrin-Associated Periodic Syndromes 01/2017 - 04/2007
4	Atherosclerosis 11/2019 - 10/2009
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2021 - 03/2003
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2021 - 09/2009
3	Spasm (Spasms) 01/2021 - 08/2005
3	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2012 - 06/2002
3	Arthritis (Polyarthritis) 01/2007 - 12/2002
2	Epilepsy (Aura) 12/2021 - 01/2015
2	Dyskinesias (Dyskinesia) 01/2021 - 03/2012
2	Infantile Spasms (West Syndrome) 01/2021 - 08/2005
2	Febrile Seizures (Febrile Seizure) 01/2019 - 01/2015
2	Partial Epilepsies (Epilepsy, Partial) 01/2015 - 10/2006
2	Dermatomyositis (Dermatopolymyositis) 03/2012 - 02/2008
2	Human Influenza (Influenza) 01/2009 - 06/2006
2	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 02/2008 - 10/2002
2	Disseminated Intravascular Coagulation 01/2008 - 01/2004
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2006 - 01/2004
1	Schizophrenia (Dementia Praecox) 01/2022
1	Plasmacytoma 10/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Infections 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2020
1	Gastroenteritis 01/2020
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 11/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Neointima 12/2015
1	Apnea 03/2015
1	Trisomy 18 Syndrome 03/2015
1	autosomal dominant familial Periodic fever 01/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2013
1	Bacterial Infections (Bacterial Infection) 06/2013
1	Thrombosis (Thrombus) 04/2013
1	Unconsciousness (Loss of Consciousness) 09/2012
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2012
1	Polymyositis 03/2012
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2012

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 11/2006
5	AutoantibodiesIBA 01/2022 - 12/2002
5	AntibodiesIBA 01/2022 - 12/2002
5	Proteins (Proteins, Gene)FDA Link 11/2019 - 06/2010
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 06/2004
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 08/2005
3	HDL LipoproteinsIBA 11/2019 - 01/2015
3	CholesterolIBA 11/2019 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2007
3	ChemokinesIBA 04/2013 - 09/2009
3	Prednisolone (Predate)FDA LinkGeneric 02/2008 - 06/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2021 - 11/2007
2	dehydroxymethylepoxyquinomicinIBA 10/2021 - 01/2007
2	Thromboplastin (Tissue Factor)IBA 06/2021 - 04/2013
2	Cardiolipins (Cardiolipin)IBA 06/2021 - 12/2002
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 12/2002
2	C-Reactive ProteinIBA 01/2020 - 06/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2019 - 01/2016
2	Biological ProductsIBA 01/2015 - 04/2007
2	InflammasomesIBA 02/2014 - 06/2010
2	Antiphospholipid AntibodiesIBA 04/2013 - 09/2009
2	Chemokine CX3CL1IBA 03/2012 - 12/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2009 - 01/2008
2	NF-kappa B (NF-kB)IBA 01/2007 - 01/2005
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2022
1	Lacosamide FDA Link 12/2021
1	Sodium Channel BlockersIBA 12/2021
1	Kisspeptin-1 ReceptorsIBA 10/2021
1	VaccinesIBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	ethyl acetateIBA 04/2020
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	CatecholaminesIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2019
1	canakinumab FDA Link 01/2017
1	HomocysteineIBA 01/2016
1	erythromycin propionate-N-acetylcysteinateIBA 12/2015
1	Actin Depolymerizing Factors (Cofilins)IBA 12/2015
1	human PRRT2 proteinIBA 01/2015
1	AntioxidantsIBA 01/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2015
1	tocilizumab (atlizumab)FDA Link 01/2015
1	NucleotidesIBA 01/2015
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	Adalimumab (Humira)FDA Link 11/2013
1	Dexmedetomidine FDA Link 04/2013
1	fibroblast growth factor 14IBA 03/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 02/2011
1	calpastatinIBA 06/2010
1	tamibaroteneIBA 10/2009

Therapy/Procedure

10	Therapeutics 01/2021 - 06/2002
3	Artificial Respiration (Mechanical Ventilation) 03/2015 - 10/2002
1	Complementary Therapies (Alternative Medicine) 04/2020
1	Thai Traditional Medicine 04/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2015
1	Lasers (Laser) 04/2013